This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Arcus Biosciences, Inc., Wuxi Biologics Ireland Limited. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2024
Title: Inventor Spotlight: Ada Pei Xian Chen
Introduction
Ada Pei Xian Chen, an influential inventor based in San Francisco, California, has made notable contributions to the field of biochemistry. With a focus on therapeutic antibodies, she has developed innovative solutions aimed at improving human health.
Latest Patents
Ada holds a patent for "Anti-CD39 antibodies and use thereof." This patent encapsulates her work on anti-CD39 antibodies that inhibit the enzymatic activity of human CD39, providing methods for their application in various therapeutic contexts. The patent represents a significant advancement in the potential treatment options available for diseases where CD39 plays a critical role.
Career Highlights
Throughout her career, Ada has worked with reputable organizations, including Arcus Biosciences, Inc. and Wuxi Biologics Ireland Limited. Her expertise in antibody development and biopharmaceutical research has established her as a key contributor in her field, reflecting her commitment to advancing medical science through innovation.
Collaborations
Ada has collaborated with talented professionals, including Christine Elizabeth Bowman and Ester Fernandez-Salas. These partnerships underscore the collaborative nature of scientific research and innovation, enhancing the potential impact of their collective work in biotechnology.
Conclusion
In summary, Ada Pei Xian Chen is a pioneering inventor whose work on anti-CD39 antibodies highlights the importance of innovation in the biotechnology sector. Her contributions not only pave the way for future research but also hold promise for developing new treatments that could improve patient outcomes in various medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile